COMMUNIQUÉS West-GlobeNewswire

Bio-on et Hera insufflent la vie à Lux-on Toute dernière initiative pour produire des bioplastiques à base de CO2.

10/12/2018 - 07:59

On annonce la fondation de la société Lux-on, par Bio-on, avec la participation du groupe Hera, dont la mission est la mise au point d’une technologie révolutionnaire pour la production de bio-polymères à partir de CO 2 [...]

Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea

10/12/2018 - 07:16

Basel, Switzerland, December 10, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the sales of the antifungal Cresemba ® (isavuconazole) by Astellas Pharma Inc. ("Astellas") in the United States [...]

Novartis data demonstrates consistent efficacy and tolerability of Kisqali® combination therapy in HR+/HER2- advanced breast cancer in patients with difficult-to-treat visceral disease

08/12/2018 - 14:01

Subgroup analyses of three pivotal Phase III MONALEESA trials showed Kisqali plus endocrine therapy extended PFS in all patients with and without visceral involvement compared to endocrine therapy alone; consistent with [...]

Arvinas Presents Preclinical Data on Protein Degrader, ARV-471, at the 2018 San Antonio Breast Cancer Symposium (SABCS)

08/12/2018 - 01:00

ARV-471 Degraded Estrogen Receptor and Provided Improved Anti-Tumor Activity When Compared to SOC, Both as a Monotherapy and in Combination NEW HAVEN, Conn., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN [...]

Segra Postpones Go Public Strategy Citing Cannabis Market Conditions

08/12/2018 - 00:36

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Segra International Corp., a cannabis agritech company, [...]

Abattis Announces Acquisition of Fertilizer Company NutriVida

08/12/2018 - 00:13

VANCOUVER, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has signed a non-binding letter of intent [...]

Emerald Health Therapeutics Closes $10.8 Million Prospectus Sale

08/12/2018 - 00:11

VICTORIA, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) ("Emerald" or the “Company”) closed today its prospectus sale (the “Offering”) to a single Canadian [...]

Supreme Court of the State of Delaware Rules Against Akorn, New CEO Search Underway

07/12/2018 - 23:04

LAKE FOREST, Ill., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX) today said it will move forward and rebuild shareholder value as an independent company following the disappointing decision from the [...]

Revive Announces a $2 Million Non-Brokered Private Placement

07/12/2018 - 23:03

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics [...]

In Memoriam: Dr. Andreas Muhs CSO, Scientific Leader and Friend has Passed Away

07/12/2018 - 22:16

Lausanne, Switzerland, December 7, 2018 - AC Immune SA (NASDAQ: ACIU), announced today that its Chief Scientific Officer, Dr. Andreas Muhs, passed away following a period of illness. "It is with great sadness that we [...]

Indiana Minority Health Coalition in partnership with Side Effects Media and The Indianapolis Recorder will host two statewide town hall meetings!

07/12/2018 - 22:13

INDIANAPOLIS, Dec. 07, 2018 (GLOBE NEWSWIRE) -- On December 11, 2018, Indiana Minority Health Coalition in partnership with Side Effects Media and the Indianapolis Recorder will host two statewide virtual town hall [...]

MacroGenics Announces Partial Clinical Hold on MGD009 Phase 1 Studies

07/12/2018 - 22:01

ROCKVILLE, MD, Dec. 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

BIOPHYTIS Announces One Oral Presentation and Two Poster Presentations at the 11th International Conference on Cachexia, Sarcopenia and Muscle Wasting

07/12/2018 - 19:47

PARIS, Dec. 07, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company developing first-in-class drug candidates for the treatment of age-related degenerative diseases [...]

ObsEva R&D Day Showcases Multiple Women’s Health Programs and Outlines Plans for Transition to Commercial Operations

07/12/2018 - 18:12

Clinical Trial Data and Regulatory Progress on Lead Programs Targeting IVF, Endometriosis, and Uterine Fibroids to Transform Company in 2019 GENEVA, Switzerland and BOSTON, Mass. (December 7, 2018) – ObsEva SA (NASDAQ: [...]

Affimed Announces U.S. Registrational Pathway and Updated Clinical Development Plan for AFM13 at R&D Day

07/12/2018 - 17:30

- Company to Pursue Registrational Pathway for Lead Agent AFM13 Monotherapy in Patients with Peripheral T Cell Lymphoma with Potential for Accelerated Approval - - Clinical Studies for AFM13 in Combination with anti-PD1 [...]

Tauriga Sciences Inc. to Register Trademark with USPTO to Support Launch of its Cannabis Infused Chewing Gum Product Line

07/12/2018 - 17:29

New York, NY, Dec. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. ( TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]

Tonix Pharmaceuticals Prices $15,000,000 Public Offering

07/12/2018 - 16:35

NEW YORK, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat [...]

Corruption Widespread in Medical Industry, States the Journal of American Physicians and Surgeons

07/12/2018 - 15:39

TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Of the more than $3 trillion dollars per year spent worldwide on health services, an untold amount is drained through corruption, according to the non-governmental [...]

OrthoPediatrics Corp. Announces Pricing of Offering of Common Stock

07/12/2018 - 15:24

WARSAW, Ind., Dec. 07, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the pricing of its [...]